Saludos a todos.
No suelo participar por mi falta de experiencia, pero me llama la atención un valor y me gustaría saber qué os parece?
El valor en cuestión es BONE.
De paso os felicito por este magnífico hilo!
http://www.smallcapnetwork.com/Are-GNOM-HP-and-BONE-Worth-Renting-Here/s/via/1789/article/view/p/mid/3/id/188/
HGSI>
Glaxo (GSK) Confirms Offer for Human Genome (HGSI), Deal Valued at $14.25/Share in Cash
FREE Breaking News Alerts from StreetInsider.com!
E-mail Address
Top News Most Read Highlighted
Citi (C) Beats Q2 Expectations of Loan and Deposit Growth, Transaction Services Performance
Par Pharmaceutical (PRX) Hugs Buyout Price as it Could See Higher Bids
Retail Sales Data Disappoints, but Shows Boon in Nonstore Sales (i.e. Online Shopping)
U.S. 5-Year Bond Makes History (TLT)
Glaxo (GSK) Confirms Offer for Human Genome (HGSI), Deal Valued at $14.25/Share in Cash
Microsoft (MSFT) to Make Another Surprise Announcement, But What's Left?
Nokia (NOK) Shares Volatile into Suprise Microsoft (MSFT) Announcement
VIVUS (VVUS) Gets a Boost from Uber-Bullish Orexigen (OREX) Call
Orexigen (OREX), Arena (ARNA) Stronger into Qnexa PDUFA
MSG (MSG) Shares Under Pressure on Possible Departure of 'Lin'-spiring Superstar
NCR's (NCR) POS Innovation, Cost Savings to Businesses Bode Well for Growth - Barron's
Will Investors Heed Peer Warnings on Intel (INTC), Microsoft (MSFT) into Quarterly Results?
VIVUS (VVUS) Gets a Boost from Uber-Bullish Orexigen (OREX) Call
Fears About Effectiveness of Facebook's (FB) Ads Linger; Shares Remain Under Pressure
Rick Sherlund Sees Possible Office 15 Announcement from Microsoft (MSFT)
July 16, 2012 9:17 AM EDT
GSK Hot Sheet
Overall Analyst Rating:
NEUTRAL ( Up)
Dividend Yield: 4.8%
EPS Growth %: -12.5% GlaxoSmithKline plc (NYSE: GSK) and Human Genome Sciences (NASDAQ: HGSI) today announced that the companies have entered into a definitive agreement under which GSK will acquire HGS for US$14.25 per share in cash.